Skip to main content

Table 3 Clinical results of external beam radiation, brachytherapy boost, with or without chemotherapy

From: The safety and usefulness of neutron brachytherapy and external beam radiation in the treatment of patients with gastroesophageal junction adenocarcinoma with or without chemotherapy

Authors (Ref.)

Hishikawa et al.[17]

Flores et al.[23]

Hareyama et al.[18]

Sharma et al.[25]

RTOG9207[16]

Present study*

No. of pts.

148

171

161

100

50

197

BT Gy/fraction

12/1

15/1

15-20/NS

15-20/1

15/3

12-25/2-6

EBRTGy/fraction

60/30

40/15

47-70/25-35

50/28

50

30-60

CT (pts)

No

No

No

Yes

Yes

88/197

Fistula (%)

5.3

5

1.2

12

12

8 (4.1%)

Bleeding (%)

0%

11

0

4

NS

13 (6.6%)

Ulcer (%)

NS

NS

3

29

NS

NS

Stricture (%)

10

35

3

16

4

4 (2%)

Death rate (%)

3

0.6

0

4

8

0

OS (%)

37 (2 y) LD

33 (1 y)

43.3/Stage I,

8 (20 Gy)

49 (1 y)

57.1 (1 y)

8 (2 y) ED

26 (2 y)

21.1/Stage II,

23 (15 Gy)

 

35.1 (2 y)

 

19 (3 y)

(5 y)

(5 y)

 

9.2 (5 y)

LRC (%)

64 (2 y) LD

NS

31.7%(5 y)

NS

35.9 (5 y)

  1. Abbreviations: CT Chemotherapy, HDR high dose rate, NS not stated, LD limited disease, ED extensive disease, y year.